Kimura's disease L98.9

Author: Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 14.11.2026

Dieser Artikel auf Deutsch

Synonym(s)

Kimura syndrome; Kimura Syndrome

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

History This section has been translated automatically.

Kimura, 1948

Definition This section has been translated automatically.

Multicentre, benign lymphoproliferative hyperplasia, characterised by subcutaneous nodules with oedema, lymphocytic and eosinophilic infiltrates, formation of germinal centres, fibrosis and hyperplasia of blood vessels. Apparently, there are differences between Kimura disease and angiolymphoid hyperplasia with eosinophilia due to clinical and histological criteria, so that the two clinical pictures can be managed as separate entities. See below Angiolymphoid hyperplasia with eosinophilia.

Occurrence/Epidemiology This section has been translated automatically.

Mainly in the Asian population, less frequently among Caucasians and Africans.

Etiopathogenesis This section has been translated automatically.

The etiology of Kimura’s disease remains unclear to this day. However, current pathogenetic theories suggest a chronic inflammatory reaction, predominantly of a Type 2 immunological nature, in which eosinophils, Th2 lymphocytes, IgE, and various cytokines interact with one another.

Four pathogenic mechanisms in particular are under discussion:

  1. Allergic-atopic immune reaction: The frequently pronounced hyper-IgEemia and eosinophilia suggest a Type 2 immune response. However, no specific triggering allergen is known.
  2. Chronic antigen stimulation: Parasitic, microbial, or other environmental antigens are discussed as possible triggers. There is no reproducible detection of pathogens or established causal relationship.
  3. Immunoregulatory dysfunction: Excessive activation of Th2 cells and eosinophils could sustain the persistent lymphatic and vascular tissue reaction.
  4. Lymphoproliferative mechanisms: The marked lymphofollicular hyperplasia indicates chronic B-cell stimulation. However, a uniform clonal or neoplastic origin has not been established.

The disease is therefore predominantly classified as a reactive immunoinflammatory disorder rather than as a primarily neoplastic process.

Manifestation This section has been translated automatically.

Men are affected significantly more often than women; the peak age is between 20 and 30 years. Occasionally, cases of the disease have also been described in children and adolescents, mostly in connection with nephrotic syndrome or dialysis.

Localization This section has been translated automatically.

Head and neck region.

Clinic This section has been translated automatically.

Single or multiple, 2-40 mm in size, hemispherical, red to reddish-brownish, more rarely purple or ulcerated cutaneous or subcutaneous nodules and nodes. Rarely disseminated occurrence or lymphadenopathy. No itching.

Laboratory This section has been translated automatically.

Significant blood eosinophilia (> 10%); increased IgE.

Histology This section has been translated automatically.

Subcutaneously localized, diffuse infiltrate of T- and B-lymphocytes and numerous eosinophils, isolated eosinophilic microabscesses, moderate fibrosis, slight edema, formation of numerous germinal centres, increased occurrence of blood vessels with epithelioid endothelials, numerous, partly solid vascular sprouts from poorly differentiated cell elements, single mast cells.

Diagnosis This section has been translated automatically.

Due to the uncharacteristic clinic, the diagnosis is made exclusively via biopsy.

Differential diagnosis This section has been translated automatically.

Therapy This section has been translated automatically.

Excision for longer periods of storage. Danger of bleeding! Recurrence treatment (but also applied as primary therapy) with fractionated x-ray radiation (GD: 20-40 Gy). Also combination of intralesional glucocorticoid application like triamcinolone acetonide crystal suspension (e.g. Volon A) diluted 1:3 with a local anaesthetic (e.g. scandicain) are described as successful.

Internal therapy This section has been translated automatically.

Test with Ciclosporin A over a period of 1/2 year.

Literature This section has been translated automatically.

  1. Hareyama M et al (1998) Radiotherapy for Kimura's disease: the optimum dosage. Int J Radiat Oncol Biol Phys 40: 647-651
  2. Helander SD et al (1995) Kimura`s disease and angiolymphoid hyperplasia: New observations from immunohistochemical studies of lymphocyte markers, endothelial antigens, and granulocyte proteins. J Cutan catheter 22: 319-326
  3. Hung CC et al (2000) Steroid-sensitive anemia in a boy on dialysis - an association with Kimura disease. Pediatric Nephrol 15: 183-185
  4. Kaneko K et al (1999) Successful tratment of Kimura's disease with cyclosporine. J Am Acad Dermatol 41: 893-894
  5. Khoo BP, Chan R (2002) Kimura disease: 2 case reports and a literature review. Cutis 70: 57-61
  6. Kimura T et al (1948) Unusual granulation combined with hyperplastic changes of lymphoid tissue. Trans Soc Pathol Jpn 37: 179
  7. Krapohl BD et al (2003) A rare vasoproliferative lesion: angiolymphoid hyperplasia with eosinophilia of the hand. Br J Plast Surgery 56: 168-170
  8. Lu HJ (2003) Kimura disease in a patient with renal allograft failure secondary to chronic rejection. Pediatric nephrol 18: 1069-1072
  9. Metze D et al (1991) Angiolymphoid hyperplasia with eosinophilia (AHE). Dermatologist 42: 101-106

Authors

Last updated on: 14.11.2026